Imiquimod (Aldara) for Actinic Keratoses
Imiquimod cream 5% (Aldara - 3M), an immune modifier previously approved for treatment of genital and perianal warts (Medical Letter 1997; 39:118), has now been approved by the FDA for treatment of actinic keratoses (AKs) on the face or scalp, and may also be approved soon for treatment of basal cell carcinoma. It produces apoptosis in malignant, but not normal, human keratinocytes (M Sch÷n et al, J Natl Cancer Inst 2003; 95:1138)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Imiquimod (Aldara) for Actinic Keratoses
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1183
Article Code: 1183b
Date: May 24, 2004
Volume: 46
Pages: 42-44
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1183
Article Code: 1183b
Date: May 24, 2004
Volume: 46
Pages: 42-44
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)